New immunotherapeutic drugs in advanced non-small cell lung cancer (NSCLC): from preclinical to phase I clinical trials

Rocco, D; Gregorc, V; Della Gravara, L; Lazzari, C; Palazzolo, G; Gridelli, C

Gridelli, C (corresponding author), SG Moscati Hosp, Div Med Oncol, I-83100 Avellino, Italy.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020; 29 (9): 1005

Abstract

Introduction The development of immune checkpoint inhibitors (ICI) has represented a revolution in the treatment of non-small cell lung cancer (NSCLC)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索